Peptide therapy TikTok claims: separating hype from human data

What did @jackmandeville actually say?

The creator laid out a goal-based peptide framework across five categories: muscle gain, body recomposition, injury recovery, aesthetics, and fat loss. For muscle, he recommended growth hormone secretagogues, IGF-1 LR3, and HCG. For recomp and fat loss, he leaned heavily on "Rhetatruitide" and "Tessemerelin" alongside IGF-1 LR3. For injury, he called BPC-157 and TB-500 "the holy grail." For aesthetics, he added GHK-Cu. He closed by offering a personalized "protocol" via DMs, which is a significant red flag on its own.

The video is short, confident, and structured like advice from someone who has done this personally. That framing, combined with the DM-based protocol offer, positions this as individualized guidance without any clinical assessment. That is not a small distinction.

Does the science back this up?

Partially, but the gaps are large enough to matter. The injury claims around BPC-157 and TB-500 have the most preclinical support. The fat loss and recomp claims rest on compounds with limited or preliminary human data. The muscle-building stack includes a compound, IGF-1 LR3, with real risks that go unmentioned.

BPC-157 has shown tissue-healing effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), and TB-500's active fragment Tβ4 has some wound-healing data in human trials, though not specifically for athletic injuries. GHK-Cu does have published evidence supporting collagen synthesis stimulation (Pickart et al., 2015, Journal of Aging Research). Growth hormone secretagogues like CJC-1295 and ipamorelin have genuine mechanistic support for increasing GH pulse amplitude (Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism). So the broad framework is not fabricated. But the confidence level in the video far outruns what the human evidence actually supports.

What did they get wrong (or right)?

The biggest problem is "Rhetatruitide" and "Tessemerelin." These appear to be phonetic approximations of retatrutide and tesamorelin. Retatrutide is a triple agonist (GIP/GLP-1/glucagon) currently in Phase 2 trials, not approved, and not a peptide you casually stack. Tesamorelin is FDA-approved, but only for HIV-associated lipodystrophy, not general fat loss or body recomposition.

Calling HCG a testosterone builder is an oversimplification. HCG mimics LH and can stimulate endogenous testosterone production, but using it without monitoring in an unsupervised stack carries real hormonal risks. The claim that these compounds create a "synergistic effect of almost just melting off fat" is not supported by any published data on combined use. IGF-1 LR3 also carries concerns around insulin sensitivity and potential mitogenic effects that are completely absent from this video. The injury stack recommendation, BPC-157 plus TB-500, is the most defensible claim here, though even that overstates certainty given the lack of large-scale human trials.

What should you actually know?

Several of the compounds named here are not approved by the FDA for the uses described. Retatrutide is investigational. Tesamorelin is prescription-only with a narrow approved indication. Compounded peptides exist in a regulatory gray area, and quality control across suppliers varies significantly. None of this makes every peptide dangerous, but it does mean the casual "stack" framing understates real considerations.

Offering personalized protocols via DMs without a clinical intake, bloodwork review, or licensed oversight is not responsible guidance, regardless of the creator's personal experience. A legitimate peptide protocol involves baseline labs, goal-setting with a clinician, and monitoring for hormonal or metabolic changes. The video presents none of that infrastructure. If you are curious about peptide therapy, that conversation belongs with a licensed provider who can review your individual health history, not an anonymous DM.